MedPath

A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

Phase 4
Active, not recruiting
Conditions
Postmenopausal Osteoporosis
Interventions
Registration Number
NCT06079476
Lead Sponsor
Amgen
Brief Summary

The primary objective of this study is to characterize safety and tolerability of romosozumab in postmenopausal women with osteoporosis and a high risk of fracture in India.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Participants diagnosed with osteoporosis who are postmenopausal and have a high risk of fracture who provided inform consent (in-person or through their legally authorized representative) to participate in the use of romosozumab per local label in India.
Exclusion Criteria
  • Participants who experienced myocardial infarction or stroke within a year prior to entering this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Phase 4: RomosozumabRomosozumabParticipants will be dosed with two subcutaneous (SC) injections of romosozumab once a month for 12 months.
Primary Outcome Measures
NameTimeMethod
Number of Participants Experiencing Clinically Significant Changes in Laboratory AssessmentsBaseline, Month 12
Number of Participants With Clinically Significant Changes in Vital SignsBaseline, Month 12
Number of Participants Experiencing Treatment-emergent Adverse Events (TEAE)Up to 12 months
Number of Participants Experiencing Treatment-emergent Serious Adverse Events (TESAE)Up to 12 months
Secondary Outcome Measures
NameTimeMethod
Percentage Change From Baseline in BMD (Measured by DXA) of the Total HipAt 6 months and 12 months
Percentage Change From Baseline in Bone Mineral Density (BMD) (Measured by Dual-energy X-ray Absorptiometry [DXA]) of the Lumbar SpineAt 6 months and 12 months
Percentage Change From Baseline in BMD (Measured by DXA) of the Femoral NeckAt 6 months and 12 months

Trial Locations

Locations (10)

Sir Ganga Ram Hospital

🇮🇳

New Delhi, Delhi, India

Apollo Hospital

🇮🇳

New Delhi, Delhi, India

Stavya Spine Hospital and Research Institute SSHRI

🇮🇳

Ahmedabad, Gujarat, India

MS Ramaiah Medical College and Hospitals

🇮🇳

Bangalore, Karnataka, India

King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College

🇮🇳

Mumbai, Maharashtra, India

Sancheti Institute for Orthopedics and rehabilitation

🇮🇳

Pune, Maharashtra, India

Post Graduate Institute of Medical Education and Research

🇮🇳

Chandigarh, Punjab, India

MGM Healthcare

🇮🇳

Chennai, Tamil Nadu, India

Christain Medical College

🇮🇳

Vellore, Tamil Nadu, India

King Georges Medical University

🇮🇳

Lucknow, Uttar Pradesh, India

© Copyright 2025. All Rights Reserved by MedPath